BA
GNCA

BlackRock Advisors’s Genocea Biosciences, Inc. GNCA Stock Holding History

BlackRock Advisors’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$16K Hold
490
– – ﹤0.01% 3503
2016
Q3 		$20K Hold
490
– – ﹤0.01% 3456
2016
Q2 		$16K Sell
490
-675
-58% -$24.7K ﹤0.01% 3498
2016
Q1 		$72K Hold
1,165
– – ﹤0.01% 3061
2015
Q4 		$49K Sell
1,165
-589
-34% -$28.1K ﹤0.01% 3197
2015
Q3 		$96K Buy
1,754
+497
+40% +$49.3K ﹤0.01% 3123
2015
Q2 		$138K Buy
1,257
+837
+199% +$77.7K ﹤0.01% 3025
2015
Q1 		$40K Buy
420
+216
+106% +$15.2K ﹤0.01% 3302
2014
Q4 		$11K Hold
204
– – ﹤0.01% 3599
2014
Q3 		$15K Sell
204
-169
-45% -$18.5K ﹤0.01% 3548
2014
Q2 		$56K Buy
373
+229
+159% +$34.7K ﹤0.01% 3238
2014
Q1 		$21K Buy
+144
New +$17.6K ﹤0.01% 3409

Other funds holding GNCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AA
AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return

BlackRock Advisors's GNCA Position: Q4 2016 in Review

BlackRock Advisors held its Genocea Biosciences, Inc. (GNCA) position steady in Q4 2016 at 490 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #3503.

BlackRock Advisors first reported a position in GNCA in Q1 2014 and has held it in 12 quarters since. The position peaked at $138K in Q2 2015. 47 funds tracked by Wall St. Rank hold GNCA as of Q4 2016.

  • BlackRock Advisors held 490 shares of Genocea Biosciences, Inc. worth $16K as of Q4 2016.
  • BlackRock Advisors left its Genocea Biosciences, Inc. share count unchanged in Q4 2016.
  • Genocea Biosciences, Inc. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3503 holding.
  • BlackRock Advisors first reported a position in Genocea Biosciences, Inc. in Q1 2014 and has held it in 12 quarters since.
  • BlackRock Advisors's Genocea Biosciences, Inc. position peaked at $138K in Q2 2015.
  • 47 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.